Literature DB >> 15592073

Escherichia coli strains causing urinary tract infection in uncircumcised infants resemble urosepsis-like adult strains.

Stéphane Bonacorsi1, Sophie Lefèvre, Olivier Clermont, Véronique Houdouin, Antoine Bourrillon, Chantal Loirat, Yannick Aujard, Edouard Bingen.   

Abstract

PURPOSE: Urinary tract infection (UTI) is the most frequent bacterial infection in infants younger than 90 days, and mainly affects uncircumcised males. In an attempt to unravel further the pathophysiology of UTI in this age group we used molecular methods to characterize Escherichia coli strains responsible for community acquired UTI in male and female infants and in adults.
MATERIALS AND METHODS: A total of 79 E. coli isolates from uncircumcised male and female infants with UTI and no urinary tract abnormalities and 41 E. coli pyelonephritis isolates from nonhost compromised adults with bacteremia were characterized in terms of phylogenic relatedness and virulence factors.
RESULTS: Males were infected by strains with a genetic background and virulence factors different from those affecting females but similar to those of adult pyelonephritis strains.
CONCLUSIONS: Our molecular approach indicates that uncircumcised male infants are at higher risk for infection with highly virulent uropathogenic E. coli strains than are females. Preputial colonization may have a key role in the selection of such strains.

Entities:  

Mesh:

Year:  2005        PMID: 15592073     DOI: 10.1097/01.ju.0000148606.07267.7d

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Newborn male circumcision.

Authors:  S Todd Sorokan; Jane C Finlay; Ann L Jefferies
Journal:  Paediatr Child Health       Date:  2015 Aug-Sep       Impact factor: 2.253

2.  Detection and identification by PCR of a highly virulent phylogenetic subgroup among extraintestinal pathogenic Escherichia coli B2 strains.

Authors:  Philippe Bidet; Arnaud Metais; Farah Mahjoub-Messai; Lionel Durand; Marie Dehem; Yannick Aujard; Edouard Bingen; Xavier Nassif; Stéphane Bonacorsi
Journal:  Appl Environ Microbiol       Date:  2007-02-09       Impact factor: 4.792

3.  Comparative prevalence of virulence factors in Escherichia coli causing urinary tract infection in male infants with and without bacteremia.

Authors:  Stéphane Bonacorsi; Véronique Houdouin; Patricia Mariani-Kurkdjian; Farah Mahjoub-Messai; Edouard Bingen
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

4.  Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version).

Authors:  Sumit Dave; Kourosh Afshar; Luis H Braga; Peter Anderson
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

5.  Multiple insertional events, restricted by the genetic background, have led to acquisition of pathogenicity island IIJ96-like domains among Escherichia coli strains of different clinical origins.

Authors:  Philippe Bidet; Stéphane Bonacorsi; Olivier Clermont; Caroline De Montille; Naima Brahimi; Edouard Bingen
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  The plasmid of Escherichia coli strain S88 (O45:K1:H7) that causes neonatal meningitis is closely related to avian pathogenic E. coli plasmids and is associated with high-level bacteremia in a neonatal rat meningitis model.

Authors:  Chantal Peigne; Philippe Bidet; Farah Mahjoub-Messai; Céline Plainvert; Valérie Barbe; Claudine Médigue; Eric Frapy; Xavier Nassif; Erick Denamur; Edouard Bingen; Stéphane Bonacorsi
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

7.  A conserved virulence plasmidic region contributes to the virulence of the multiresistant Escherichia coli meningitis strain S286 belonging to phylogenetic group C.

Authors:  Chloé Lemaître; Farah Mahjoub-Messai; Damien Dupont; Valérie Caro; Laure Diancourt; Edouard Bingen; Philippe Bidet; Stéphane Bonacorsi
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.